What is the Purpose of this Study?
Incidence of CTRCD in Cardio-Oncology services in all participating centers. 2. Identify risk factors resulting in increased CTRCD, and validate risk score models. 3. Evaluate geographic and regional differences in use of biomarkers and imaging modalities, and its impact of management of CTRCD. 4. Evaluate impact of socioeconomic and demographic variables in access to care, utilized surveillance strategies, treatments and outcomes. 5. Describe outcomes of cancer survivors treated with different potential cardio-toxic modalities in different geographic locations. 6. Provide a platform for multiple collaborations, sub-studies and prospective clinical studies.
Eligibility
- * New cardio-oncology consultation for breast cancer patients, or
- * New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
- * New cardio-oncology consultation for acute or chronic leukemia patients, or
- * New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
Where can I participate?
Torrance Memorial Medical Center (CSMC Affiliate)
More about this Clinical Trial
What is the full name of this clinical trial?
Global Cardio Oncology Registry Protocol